Negotiators Prioritize Generic And Biosimilar Oncology Drugs Over Newer Medicines

UICC And WHO Will Bargain For Cheaper Cancer Drugs For LMICs

 
• By Chloe Kent
  
Pills and syringes lying on top of a sheet of paper reading 'Cancer treatment'
Lack of screening and treatment in LMICs is leading to high cancer mortality • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Policy & Regulation